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The laboratory rat has been widely used as an animal model in biomedical science for more 
than 150 years. Applying zinc-finger nucleases or transcription activator-like effector 
nucleases to rat embryos via microinjection is an efficient genome editing tool for 
generating targeted knockout rats. Recently, clustered regularly interspaced short 
palindromic repeats (CRISPR)/CRISPR-associated endonucleases have been used as an 
effective tool for precise and multiplex genome editing in mice and rats. In this review, the 
advantages and disadvantages of these site-specific nuclease technologies for genetic 
analysis and manipulation in rats are discussed. 
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Genetically modified animals that have been altered using gene targeting technologies are 
used as experimental models to perform functional analyses or various tests in biomedical 
research. In particular, knockout (KO) animals can help in understanding how a specific 
gene functions in vivo. The gene targeting technologies used to produce KO mice using 
embryonic stem (ES) cells were developed prior to 1990 (Mansour et al., 1988, Capecchi, 
1989a). Since then, KO mice have become major tools for functional gene analysis. 
Causative genes for specific human diseases have also been disrupted in mice to mimic 
human genetic disorders (Capecchi, 1989b, Smithies, 1993). In the post-genome era, the 
International Knockout Mouse Consortium (IKMC), which aims to comprehensively 
disrupt all protein-coding genes in the mouse genome using gene targeting technologies, is 
now progressing (Skarnes et al., 2004, Nord et al., 2006, Ayadi et al., 2012). Furthermore, 
knock-in (KI) mice, in which genes are added or modified, or conditional knockout mice 
with spatial or temporal control of genetic inactivation, are widely used. Gene targeting 
technologies have become critical tools for understanding gene functions including the 
genetic basis of human diseases. 
Until recently it was difficult to produce mammalian KO animals other than mice 
using gene targeting technologies, as germline-competent ES cells were available only for 
mice. However, this situation changed with the availability of newly developed gene 
targeting technologies, called engineered nucleases or “gene scissors”. These engineered 
nucleases, such as zinc finger nucleases (ZFNs) or transcription activator-like effector 
nucleases (TALENs), are very effective, as shown when treating embryos via 
microinjection to generate targeted KO mice and rats (Geurts et al., 2009, Carbery et al., 
2010, Mashimo et al., 2010, Meyer et al., 2010, Urnov et al., 2010, Cui et al., 2011, Tesson 
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et al., 2011, Mashimo et al., 2013, Sung et al., 2013). In addition to rodents, sea urchins 
(Ochiai et al., 2010), Drosophila (Beumer et al., 2006, Beumer et al., 2008), crickets (Watanabe et al., 
2012), killifish (Ansai et al., 2012, Ansai et al., 2013), and zebrafish (Doyon et al., 2008, Meng 
et al., 2008, Huang et al., 2011, Sander et al., 2011), as well as larger animals such as rabbits 
(Flisikowska et al., 2011, Song et al., 2013), and pigs (Watanabe et al., 2010, Hauschild et al., 
2011, Carlson et al., 2012), and monkeys, have been successfully modified using these 
enzymes. In this review, the advantages and disadvantages of these site-specific nuclease 
technologies are discussed in relation to genetic analysis and manipulation in animals, 
especially in rats.  
 
Zinc-finger nucleases 
ZFNs are chimeric proteins that consist of a specific DNA-binding domain that is made of 
tandem zinc finger-binding motifs fused to a non-specific cleavage domain of the restriction 
endonuclease FokI (Bibikova et al., 2001, Porteus & Carroll, 2005, Wu et al., 2007) (Fig. 1). 
As one zinc finger unit binds with 3-bp of DNA, 9–18 bp sequences can be specifically 
recognized by combining 3–6 different zinc finger units. By designing two zinc finger 
motifs on either side of 5–6 bp spacer sequences at a target region, the FokI nuclease 
combined with the zinc finger can introduce a double-strand break (DSB) within the 5–6 bp 
spacer sequences. Although the DSB is usually repaired via non-homologous end joining 
(NHEJ), an arbitrary deletion or deletion of base pairs often occurs during the repair process. 
Consequently, repair by NHEJ is mutagenic and mostly results in a loss-of-function 
mutation. Moreover, if DNA fragments homologous to the targeted sequences are 
co-injected with the nucleases, homologous recombination (HR) can occur, enabling 
insertion of a transgene or replacement of the homologous sequences at the targeted region, 
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which results in KI mutations. Therefore, artificially designed ZFNs can be used to generate 
KO or KI alleles at the targeted sequences via NHEJ or HR repair, respectively. 
A summary of how to generate targeted KO rats using ZFNs is given in Fig. 1. 
Briefly, two ZFNs are designed across the spacer domain to recognize the targeted DNA 
sequences. Messenger RNAs are then transcribed in vitro from the two ZFN plasmids and 
injected into the male pronuclei of rat zygotes. Pronuclear stage embryos are collected from 
female rats that were superovulated by equine chorionic gonadotropin and human chorionic 
gonadotropin injection. The ZFN-injected embryos that differentiate into two cells are then 
transferred to the oviduct of pseudopregnant females. This method is based on a similar 
technique used to produce conventional transgenic animals (Palmiter et al., 1982, Palmiter 
et al., 1983, Mullins et al., 1990), except that mRNA is used. The procedure for the 
micromanipulation of embryos is the same for all nucleases, including the below-mentioned 
TALEN and clustered regularly interspaced short palindromic repeats (CRISPR) enzymes. 
The ZFN technology was first reported in the 1990s (Kim et al., 1996, 
Chandrasegaran & Smith, 1999). From the 2000s, ZFNs have been developed for various 
mammalian cells (Bibikova et al., 2001, Bibikova et al., 2003, Porteus & Baltimore, 2003, 
Urnov et al., 2005, Hockemeyer et al., 2009), with nematode and zebrafish ZFNs 
developed in 2006 (Morton et al., 2006) and 2008 (Doyon et al., 2008, Meng et al., 2008) 
respectively. The first genetic modification (KO) in rats was reported in 2009 (Geurts et al., 
2009). In model organisms where ES cells could not be used for gene modifications, this 
technology has been widely applied for generating genetically modified animals, especially 
in laboratory animals other than mice. Using this ZFN technology, we developed an 
interleukin-2 receptor gamma chain (Il2rg) KO rat (X-SCID) to investigate human X-linked 
severe combined immunodeficiency (X-SCID) (Mashimo et al., 2010). SCID rats that are 
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deficient in the Prkdc gene and FSG (F344-scid Il2rg) rats that are simultaneously deficient 
in both the Prkdc and Il2rg genes have also been generated using the ZFN technology 
(Mashimo et al., 2012). In contrast to the “leaky” phenotype of the SCID mouse, where 
immunoglobulins such as IgG, are detected in the blood, SCID rats did not show such a 
leaky phenotype (Mashimo et al., 2012). These SCID rats can be used as hosts for 
xenotransplantation of human stem cells and tissues. 
 
Transcription activator-like effector nucleases 
ZFNs provide a straightforward strategy for targeted gene disruption in zygotes, resulting in 
rapid and cost-effective knockouts compared with conventional technology using ES cells. 
However, there are hurdles in terms of cost and protocols, making it difficult to establish 
ZFNs as a routine laboratory process. Recently, an artificial nuclease technology similar to 
ZFN, called TALENs, has been reported (Bogdanove & Voytas, 2011, Wood et al., 2011, 
Mussolino & Cathomen, 2012, Joung & Sander, 2013). Natural TAL effectors are potent 
virulence proteins from plant-pathogenic Xanthomonas bacteria that are injected into 
eukaryotic host cells where they function as transcription factors (Bogdanove & Voytas, 
2011). As fusions of TAL effectors to the FokI nuclease, TALENs can bind and cleave DNA 
in pairs (Fig. 1). Although the sequences recognized by ZF domains are limited in ZFNs, 
TAL effectors can recognize almost any sequence, except T at position 0. Simple and 
straightforward design and assembly strategies have been developed for rapid construction 
of TALENs (Carbery et al., 2010, Cermak et al., 2011, Sakuma et al., 2013), providing a 
cost-effective targeted nuclease platform. 
 TALEN technology has also been reported in induced pluripotent stem cells 
(iPSCs) (Hockemeyer et al., 2011), nematodes (Wood et al., 2011), plants (Li et al., 2012), 
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zebrafish (Huang et al., 2011, Sander et al., 2011), and rats (Tesson et al., 2011). Although 
TALEN technologies seem to have advantages over ZFNs, there are also some ambiguous 
points that need to be clarified. For unknown reasons, the system appears to be less 
effective in rodent embryos. However, we recently showed that combined expression of 
exonuclease 1 (Exo1) with engineered site-specific TALENs provided highly efficient 
disruption of the endogenous gene in rat zygotes, and in the production of knockout rats for 
the albino (Tyr) gene (Mashimo et al., 2013). The microinjection of TALENs with Exo1 is 
an easy and efficient method of generating gene knockouts using zygotes, which increases 
the range of gene targeting technologies available to various species. 
 
Clustered regularly interspaced short palindromic repeats 
(CRISPR)/CRISPR-associated (Cas) protein 
The bacterial CRISPR/Cas system has recently been identified as an efficient gene-targeting 
technology in mammalian cells (Bassett et al., 2013, Friedland et al., 2013, Hwang et al., 
2013, Li et al., 2013a, Li et al., 2013b, Wang et al., 2013). The system consists of a 
CRISPR that produces RNA components, along with the CRISPR-associated (Cas) 
nuclease protein. The CRISPR RNAs (crRNAs), containing short stretches of sequence 
homologous to specific target DNA, act as guides to direct Cas nucleases to introduce 
DSBs at the targeted DNA sequences. A synthetic chimeric guide RNA (gRNA) consisting 
of a fusion between crRNA and trans-activating crRNA (tracrRNA), directs Cas9 to cleave 
target DNAs that are complementary to the crRNA (Mali et al., 2013). In addition to the 
ability to easily generate synthetic gRNAs, a significant advantage of the CRISPR/Cas 
system is that multiplex genes can be targeted simultaneously with multiple targeted 
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gRNAs. Furthermore, studies in mice have shown that homology-directed repair is 
preferentially activated over the NHEJ pathway when providing donor DNA templates 
(Wang et al., 2013, Yang et al., 2013). We have constructed the CRISPR/Cas architectures 
in rats, and applied it to embryos together with single-strand DNA oligonucleotides as 
donor templates, which efficiently generated targeted KI mutations in rats (unpublished 
data). Over the last decade, the emerging technology of next generation sequencing, and 
thereby genome wide association studies (Davey et al., 2011, Biesecker & Spinner, 2013), 
has successfully identified numerous common SNPs in the human genome associated with 
important human diseases. As the functional testing of particular human SNP variants is a 
challenging proposition, accurate genome editing technologies are required for generating 
KI rats carrying equivalent mutations to human polymorphisms, rather than the KO models 
where entire coding genes are deleted. The CRISPR/Cas system provides sophisticated and 
flexible gene-targeting tools for generating suitable animal models of human diseases. 
 
Advantages of the site-specific nuclease technologies 
All of the artificial nuclease ZFN/TALEN/CRISPR technologies share the following 
advantages as compared with the conventional ES cell technology (Fig. 2). First and 
foremost, KO rats can be generated in a 4–6-month timeframe and with an efficiency of 
more than 20%. This is more favorable than the ES cell-based method for mice, which 
usually takes 12–18 months. Given the high rate of germ line transmission, preliminary 
phenotypic analysis can be performed on G1 animals after intercrossing the initial G0 
founders, thereby saving time and effort. Second, gene targeting with artificial nucleases is 
not strain dependent (unpublished data), and accordingly can be performed with any inbred 
strain. This provides a straightforward strategy for directly employing targeted gene 
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disruption in existing strains, thereby bypassing tedious and time-consuming backcrossing 
steps that generally take 2–3 years to complete. Third, the artificial nuclease technologies 
can be used to induce a wide variety of allelic changes covering small or large deletions or 
insertions. It is also feasible to use targeted KI technologies that have thus far been 
inaccessible without rat ES cells. Since the technology does not rely on using 
species-specific ES cell lines, it may be possible to adapt it to other mammalian species 
such as pigs, cattle, and monkeys, where it is possible to harvest and manipulate fertilized 
embryos. The off-target effects are one of the biggest unknowns concerning the use of 
ZFN/TALEN/CRISPR technologies to modify the targeted genes (Radecke et al., 2010, Fu 
et al., 2013). It is always important to backcross the mutant lines with multiple generations 
to eliminate any off-target mutation and/or to validate the phenotypes with at least two 
independent lines. 
The efficient production of inheritable genetically modified animals by artificial 
nuclease ZFN/TALEN/CRISPR technology will progress very rapidly. These 
genome-editing techniques will dramatically accelerate the development of advanced 
medical studies, drug design, and regenerative medicine, among other biomedical research 
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Figure legends  
Figure 1. Gene targeting technologies with ZFNs, TALENs, and CRISPR/Cas in rats. 
Schematic representation of the genetic engineering methods used for generating targeted 
knockout rats. 
 
Figure 2. Various targeted genome modifications using ZFNs, TALENs, and 
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